Literature DB >> 12117460

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Domenic A Sica.   

Abstract

Entities:  

Year:  2002        PMID： 12117460     DOI： 10.1007/s11906-996-0011-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  7 in total

Review 1.  Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.

Authors:  S E Kjeldsen; S Julius; T Hedner; L Hansson
Journal:  Blood Press       Date:  2001       Impact factor: 2.835

2.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors:  L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

3.  Use of ramipril in preventing stroke: double blind randomised trial.

Authors:  Jackie Bosch; Salim Yusuf; Janice Pogue; Peter Sleight; Eva Lonn; Badrudin Rangoonwala; Richard Davies; Jan Ostergren; Jeff Probstfield
Journal:  BMJ       Date:  2002-03-23

4.  Ramipril and the development of diabetes.

Authors:  S Yusuf; H Gerstein; B Hoogwerf; J Pogue; J Bosch; B H Wolffenbuttel; B Zinman
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

5.  Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension.

Authors:  P Verdecchia; C Porcellati; G Reboldi; R Gattobigio; C Borgioni; T A Pearson; G Ambrosio
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

6.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

7.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321
  7 in total
  3 in total

1.  Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells.

Authors:  Yoo Na Jang; Yong Jik Lee; Yoon Mi Han; Hyun Min Kim; Hong Seog Seo; Ji Hoon Jeong; Seung Yeon Park; Tae Woo Jung
Journal:  Yonsei Med J       Date:  2022-06       Impact factor: 3.052

2.  Intake of isoflavones reduces the risk of all-cause mortality in middle-aged Japanese.

Authors:  Mariko Nakamoto; Rei Otsuka; Chikako Tange; Yukiko Nishita; Makiko Tomida; Tomoko Imai; Tohru Sakai; Fujiko Ando; Hiroshi Shimokata
Journal:  Eur J Clin Nutr       Date:  2021-03-12       Impact factor: 4.016

3.  Dietary Diversity and All-Cause and Cause-Specific Mortality in Japanese Community-Dwelling Older Adults.

Authors:  Rei Otsuka; Chikako Tange; Yukiko Nishita; Yuki Kato; Makiko Tomida; Tomoko Imai; Fujiko Ando; Hiroshi Shimokata
Journal:  Nutrients       Date:  2020-04-10       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.